Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-16

FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

The FDA approved Accord Healthcare's supplemental application for a generic escitalopram product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM)